Replies to post #1953 on Conatus Pharmaceuticals Inc. (CNAT)

[buckysherm]

As your icon would say, “Ex-cellent !”

[Millions242]

Theo, Thank you so much for the summary and your honest analysis. I will buy more on the dip tomorrow.

[Theo]

From the MSMONEY article:

Conclusion
Despite missing their primary endpoint, there is still a lot of potential upside for Conatus. The important thing is a clear pattern of decreasing HVPG among the Emricasan treatment groups compared to the placebo arm.

Which is EXACTLY what I said the day they released results:

1) Mean HVPG in ALL emricasan dose groups DECREASED in ALL compensated cohorts while mean HVPG in the placebo cohort INCREASED....Emricasan is doing exactly what it is supposed to do... albeit perhaps not at the magnitude they had hoped. However, it IS, none the less, consistent across ALL groups which means it's NOT a fluke.